Skip to main content

Table 1 Prevalence of VRSA in S. aureus and VRSA in MRSA based on quality, continent, countries, isolate source, and AST method

From: RETRACTED ARTICLE: Systematic review and meta-analysis of the epidemiology of vancomycin-resistance Staphylococcus aureus isolates

Subject

Sub group

No. studies

No. strains

Proportion (95% CI)

%Weight

P

I2

P sig

Overall

VRSA

62

12,816

0.06 (0.04, 0.09)

100

0

0.9574

0

VRSA from MRSA

25

3925

0.06 (0.03, 0.09)

100

0

0.9366

0

Quality

        

High quality

VRSA

43

10,990

0.05 (0.03, 0.07)

70.83

0

0.9599

0

VRSA from MRSA

19

3390

0.07 (0.03, 0.12)

68.85

0

0.9531

0

Low quality

VRSA

19

1826

0.1 (0.04, 0.17)

28.68

0

0.9460

0

VRSA from MRSA

9

675

0.02 (0.01, 0.05)

31.15

0.03

0.5328

0

Continent

        

Asia

VRSA

46

11,074

0.05 (0.03, 0.08)

75.03

0

0.9555

0

VRSA from MRSA

22

3416

0.06 (0.03, 0.11)

82.07

0

0.9443

0

South America

VRSA

2

171

0.03 (0.00, 0.17)

1.39

  

0.16

VRSA from MRSA

 

–

     

Africa

VRSA

7

720

0.16 (0.03, 0.35)

11.20

0

0.9706

0

VRSA from MRSA

1

50

0.00 (0.00, 0.07)

3.06

  

0

America

VRSA

3

395

0.04 (0.02, 0.07)

6.48

0.23

0.3054

0

VRSA from MRSA

2

272

5(0.03, 0.08)

8.08

  

1

Europe

VRSA

4

456

0.01 (0, 0.05)

5.90

0.03

0.6616

0.14

VRSA from MRSA

2

187

0 (0, 0.02)

6.19

  

0.87

Countries

        

Pakistan

VRSA

5

934

0.1 (0.01, 0.24)

8.40

0

0.9693

0.01

VRSA from MRSA

3

301

0.07 (0, 0.25)

11.61

  

0.06

India

VRSA

14

5647

0.07 (0.03, 0.13)

23.42

0

0.9778

0

VRSA from MRSA

6

3529

0.06 (0, 0.18)

23.50

0.01

0.98

0.03

Brazil

VRSA

3

203

0.03 (0.01, 0.07)

4.48

0.00

0

0

VRSA from MRSA

1

140

0.04 (0.01, 0.08)

4.08

  

0

Nigeria

VRSA

2

273

0.29 (0.24, 0.35)

3.30

  

0

VRSA from MRSA

–

      

Iran

VRSA

16

3464

0.02 (0.01, 0.04)

26.28

0

0.7848

0

VRSA from MRSA

6

875

0.04(0.01, 0.08)

23.20

0.01

67.03

 

Algeria

VRSA

3

583

0.01 (0, 0.04)

1.72

  

0.01

VRSA from MRSA

1

220

0.02 (0, 0.05)

4.08

  

0.01

USA

VRSA

2

363

0.04 (0.02, 0.07)

3.39

  

0

VRSA from MRSA

1

132

0.08 (0.04, 0.13)

3.66

  

0

Italy

VRSA

3

448

0.02 (0, 0.05)

5.03

  

0.02

VRSA from MRSA

1

179

0.01 (0, 0.04)

4.10

  

0.03

Saudi Arabia

VRSA

2

128

0.18 (0.12, 0.26)

3.02

  

0

VRSA from MRSA

1

98

0.15 (0.09, 0.24)

3.95

  

0

Tanzania

VRSA

1

53

0.11 (0.04, 0.23)

1.53

  

0

VRSA from MRSA

–

–

. (.,.)

    

Egypt

VRSA

4

394

0.16 (0.01, 0.45)

6.36

0

0.9719

0.02

VRSA from MRSA

1

50

0 (0, 0.07)

3.66

  

1

Turkey

VRSA

5

469

0.05 (0, 0.14)

7.65

0

0.8895

0.02

VRSA from MRSA

3

245

0.04 (0, 0.13)

9.56

  

0.1

Bangladesh

VRSA

2

73

0.12 (0.05, 0.21)

2.86

  

0

VRSA from MRSA

2

73

0.27 (0.13, 0.43)

5.76

  

0

Germany

VRSA

1

8

0.13 (0, 0.53)

0.87

  

0.15

VRSA from MRSA

1

8

0.13 (0, 0.53)

2.09

  

0.15

Jordan

VRSA

1

139

0.04 (0.01, 0.08)

1.68

  

0

VRSA from MRSA

–

–

. (.,.)

    

Isolate source

        

Clinical

VRSA

53

11,891

0.06 (0.04, 0.08)

84.56

0

0.9582

0

VRSA from MRSA

23

5779

0.06 (0.03, 0.10)

85.92

0

0.9420

0

Clinical, non-clinic

VRSA

4

501

0.14 (0.00, 0.44)

06.54

0

0.9815

0.04

VRSA from MRSA

1

179

0.01 (0.00, 0.04)

04.10

  

0.03

Non-clinical

VRSA

6

424

0.07 (0.01, 0.15)

8.91

0

0.8615

0

VRSA from MRSA

3

245

0.04 (0.00, 0.13)

9.98

  

0.10

AST method(s)

        

MIC-base

VRSA

25

5671

0.07 (0.04, 0.12)

39.87

0

0.9599

0

VRSA from MRSA

9

1223

0.09 (0.03, 0.17)

30.99

0

0.874

0

Mixed-methods

VRSA

32

6596

0.04 (0.02, 0.07)

51.95

0

0.9527

0

VRSA from MRSA

17

4995

0.04 (0.01, 0.09)

64.48

0

0.9538

0

Disk diffusion

VRSA

33

6736

0.12 (0.02, 0.27)

8.18

0

0.9532

0

VRSA from MRSA

1

85

0.05 (0.01, 0.17)

3.52

  

0.03

  1. I2: the percentage of variance in a meta-analysis that shows study heterogeneity. VRSA: Vancomycin-resistant Staphylococcus aureus. MRSA: Methicillin-resistant Staphylococcus aureus. AST: Antimicrobial Susceptibility Testing. MIC: minimum inhibitory concentration